https://www.wsj.com/livecoverage/russia-ukraine-latest-news-2022-02-26/card/gMS7VIk7WuZXVnVxh8Ju#:~:text=FedEx%20Corp.%20and%20United%20Parcel,plans%20for%20their%20Russian%20operations.
eFFECTOR Therapeutics Q4 EPS $(0.22) Beats $(0.24) Estimate, Sales $674.00K Beat $660.00K Estimate
eFFECTOR Therapeutics (NASDAQ:EFTR) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.24) by 8.33 percent. This is a 150 percent decrease over earnings of $0.44 per share
